Moderna cuts five programmes to save $1.1bn in R&D costs - MSN

Moderna Cuts Five Programmes To Save $1.1bn In R&D Costs - MSN

2 weeks from now

Moderna cuts five programmes to save $1.1bn in R&D costs. Story by Jenna Philpott • 1w. ... Moderna also said it plans to break even on an operating cash cost basis in 2028, two years …

msn.com

Moderna Targets $1.1B In R&D Spending Cuts, Drops 5 Programs …

2 weeks from now

Sep 12, 2024  · Moderna aims to generate the savings through portfolio reprioritizations and cost efficiencies. Cutting the budget will take time, with Moderna forecasting R&D spending of $4.2 …

fiercebiotech.com

Moderna Stock Drops On Plans To Cut $1.1B In R&D Costs - MSN

2 weeks from now

Moderna projects fiscal 2025 revenue of between $2.5 billion to $3.5 billion compared to analyst projections of $2.9 billion, and said Thursday that it expects to break even on an operating …

msn.com

Moderna Will Cut $1.1bn Off Its Annual R&D Spend

2 weeks from now

5 days ago  · With COVID-19 revenues now shrinking fast, Moderna chief executive Stéphane Bancel has taken the decision to rein in spending and reduce the number of active …

pharmaphorum.com

Moderna To Cut Costs, Trim Pipeline In R&D Revamp

2 weeks from now

Sep 12, 2024  · Dive Brief: Moderna will cut R&D spending by 20% and trim its pipeline as part of a strategic overhaul that will shift its research focus and put more resources into products that …

biopharmadive.com

Moderna To Cut R&D Spending $1.1 B - STAT

2 weeks from now

Sep 12, 2024  · Moderna said Thursday it would cut its annual spending on research and development by 23%, or $1.1 billion, between 2024 and 2027 in a concession to investors who …

statnews.com

Moderna Plunges As Sales View Disappoints, Research Budget Cut

2 weeks from now

Sep 12, 2024  · The biotech is discontinuing five programs in its pipeline and slowing some late-stage studies of treatments for latent and rare diseases to achieve the $1.1 billion cut from its …

bloomberg.com

Moderna To Slash Costs By $1.1B - LinkedIn

2 weeks from now

Sep 12, 2024  · Moderna plans to cut costs by $1.1 billion by 2027 as the biotech company realigns its business amid waning demand for its COVID-19 vaccine. ... Moderna plans $1.1B …

linkedin.com

Moderna Crashes After Slashing Its R&D Budget By $1.1 Billion

2 weeks from now

Sep 16, 2024  · Moderna stock crashed Thursday after the Covid vaccine maker slashed its R&D budget by $1.1 billion and issued light 2025 sales guidance. The company says its investment …

investors.com

Moderna Shares Plunge On Plans To Cut $1.1 Billion In Costs ... - MSN

2 weeks from now

Moderna said it plans to cut $1.1 billion in expenses by 2027 as it charts a path forward after the rapid decline of its Covid business. The biotech company said it expects 10 new product ...

msn.com

Moderna Stock Plunges As Vaccine Maker Slashes R&D Budget

2 weeks from now

Sep 12, 2024  · In the release, Moderna also said it anticipates fiscal 2025 revenue to be in the range of $2.5 billion to $3.5 billion and sales to grow at a 25% compound annual growth rate …

kiplinger.com

Moderna's Spending Cuts, Pipeline Shakeup Leave Doubts About A …

2 weeks from now

Sep 13, 2024  · The J.P. Morgan analysts downgraded Moderna's stock to underweight from neutral, and cut their price target to $70, from $88. Moderna's stock is down 33% in the year to …

morningstar.com

Moderna Gets Analyst Downgrade After $1.1B R&D Spending Cut

2 weeks from now

Sep 13, 2024  · Shares of Moderna fell Friday after taking on steep losses a day earlier on the news that it plans to cut research and development spending by $1.1 billion by 2027.

investopedia.com

Moderna, Trailing Rivals, Checks Its RSV Shot Expectations

2 weeks from now

Sep 13, 2024  · Moderna also disclosed cuts to research spending and the discontinuation of several pipeline projects. The biotech plans to reduce R&D spending by $1.1 billion annually …

biopharmadive.com

Moderna’s Spending Cuts, Pipeline Shakeup Leave Doubts About A …

2 weeks from now

The J.P. Morgan analysts downgraded Moderna’s stock to underweight from neutral, and cut their price target to $70, from $88. Moderna’s stock is down 33% in the year to date, while the S&P …

msn.com

Moderna To Cut Over $1 Billion By 2027, Aims For New Vaccine …

2 weeks from now

Sep 12, 2024  · Moderna projects 2025 revenue between $2.5 billion and $3.5 billion and expects a 25% annual growth rate as new products launch by 2026. More for You Top 10 Best US …

msn.com

Moderna Lowers Full-Year Revenue Outlook, Plans To Cut Cash …

2 weeks from now

Moderna (MRNA) shares fell intraday Monday after the company cut its full-year revenue outlook while the drugmaker aims to reduce cash costs by $1 billion in 2025 amid its ongoing cost …

msn.com